Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology
Biogen
Biogen
1 article from Biogen indexed by Voice Herald. Below is what Biogen covers most and which stories they have contributed to.